作者：
Jennings,V.A. [1]
;
Ilett,E.J. [2]
;
Scott,K.J. [3]
;
West,E.J. [4]
;
Vile,R. [5]
;
Pandha,H. [6]
;
Harrington,K. ;
Young,A. ;
Hall,G.D. ;
Coffey,M. ;
Selby,P. ;
Errington-Mais,F. ;
Melcher,A.A.
作者单位：
Targeted and Biological Therapies Group, Leeds Institute of Molecular Medicine, University of Leeds
[1]
Molecular Medicine Program, Department of Immunology, Mayo Clinic, Rochester, MN, United States
[2]
Oncolytics Biotech Incorporated, Calgary, AB, Canada
[3]
Cardiovascular and Cancer Research Group, Faculty of Health and Medical Sciences, University of
[4]
St. James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
[5]
Division of Cancer Biology, Institute of Cancer Research, Chester Beatty Laboratories, London
[6]
发布时间
2014-03-06
换一批
